Coordinated care allows a patient’s treatment plan to be determined in one visit.
St. Louis Children’s Hospital Foundation’s Guardians magazine features a former proton patient who has been cancer-free since January 2016.
One of the first two MRIdian Linac Systems in the United States will be installed in the Department of Radiation Oncology at Washington University. The machine, developed by ViewRay, Inc., has recently received FDA 510(k) clearance, allowing it to be marketed in the United States. The MRIdian Linac System will feature magnetic resonance imaging to […]
The Radiation Oncology Practice Assessment Program (Co-PIs:Jeff Michalski, MD and Sasa Mutic, PhD) has received an additional $3.8 million in funding. Read more from Siteman Cancer Center »
This state-of-the-art tool incorporates MRI and radiation therapy real time, allowing physicians to see a tumor as they treat it. View »
Congratulations to the 8 Washington University Radiation Oncologists who have been recognized by Best Doctors, Inc and St. Louis Magazine as some of the Best Doctors of 2015-2016! This annual survey recognizes outstanding physicians from across the country, including 1267 from the St. Louis area. This year’s honorees include:
Siteman Cancer Center and St. Louis Children’s Hospital have launched a new partnership focused on treating children and adolescents with cancer using the latest, most effective treatments, in a setting oriented toward younger patients and their families. Read more »
Dr. Jeff Michalski is currently researching the potential for lowering the radiation risk for children undergoing treatment for medullo blastoma. View article »
Dr. Stephanie Perkins was recently interviewed by ABC News for her successful treatment of rhabdomyosarcoma in a young child using the ViewRay MRIdian machine. Read More »
Dr. Jeff Michalski has been elected as the radiation oncology co-chair of the National Cancer Institute’s genitourinary cancers steering committee, a group that works to evaluate and prioritize clinical trials conducted through the National Clinical Trials Network (NCTN).